<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Traditional Chinese medicine &#8211; Accestra Consulting</title>
	<atom:link href="https://www.accestra.com/tag/traditional-chinese-medicine/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.accestra.com</link>
	<description>Your long term strategic partner for regulatory compliance.</description>
	<lastBuildDate>Fri, 12 Jul 2019 06:25:41 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.5.6</generator>

<image>
	<url>https://www.accestra.com/wp-content/uploads/2019/03/cropped-accestra2-32x32.png</url>
	<title>Traditional Chinese medicine &#8211; Accestra Consulting</title>
	<link>https://www.accestra.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2018 Drug Review and Approval Report of China CDE (Part III- Traditional Chinese Medicine)</title>
		<link>https://www.accestra.com/2018-drug-review-and-approval-report-of-china-cde-part-iii-traditional-chinese-medicine/</link>
		
		<dc:creator><![CDATA[mona.zhang]]></dc:creator>
		<pubDate>Fri, 12 Jul 2019 06:25:40 +0000</pubDate>
				<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[CDE 2018 report]]></category>
		<category><![CDATA[China CDE]]></category>
		<category><![CDATA[IND]]></category>
		<category><![CDATA[NDA]]></category>
		<category><![CDATA[Review and approval]]></category>
		<category><![CDATA[Traditional Chinese medicine]]></category>
		<guid isPermaLink="false">http://www.accestra.com/?p=2519</guid>

					<description><![CDATA[On 2nd July, 2019, China CDE-NMPA published the 2018 working Report, summarizing the drug review and approval statistic data in the past year. See below for the details. 8- Statistic of Traditional Chinese Medicine – Overall 9- Statistic of Traditional Chinese Medicine -IND 10- Statistic of Traditional Chinese Medicine -NDA]]></description>
										<content:encoded><![CDATA[
<p>On 2<sup>nd</sup> July, 2019, China CDE-NMPA
published the 2018 working Report, summarizing the drug review and approval
statistic data in the past year.</p>



<p>See below for the details.</p>



<p><strong>8- Statistic of  Traditional Chinese Medicine  – Overall</strong></p>



<div class="wp-block-image"><figure class="aligncenter is-resized"><img fetchpriority="high" decoding="async" src="https://www.accestra.com/wp-content/uploads/2019/07/17.png" alt="" class="wp-image-2523" width="621" height="370" srcset="https://www.accestra.com/wp-content/uploads/2019/07/17.png 924w, https://www.accestra.com/wp-content/uploads/2019/07/17-300x179.png 300w, https://www.accestra.com/wp-content/uploads/2019/07/17-768x458.png 768w, https://www.accestra.com/wp-content/uploads/2019/07/17-600x358.png 600w" sizes="(max-width: 621px) 100vw, 621px" /><figcaption> Figure 17. Traditional Chinese medicine application total number from 2015 to 2018 </figcaption></figure></div>



<div class="wp-block-image"><figure class="aligncenter is-resized"><img decoding="async" src="https://www.accestra.com/wp-content/uploads/2019/07/18.png" alt="" class="wp-image-2524" width="638" height="380" srcset="https://www.accestra.com/wp-content/uploads/2019/07/18.png 926w, https://www.accestra.com/wp-content/uploads/2019/07/18-300x179.png 300w, https://www.accestra.com/wp-content/uploads/2019/07/18-768x457.png 768w, https://www.accestra.com/wp-content/uploads/2019/07/18-600x357.png 600w" sizes="(max-width: 638px) 100vw, 638px" /><figcaption> Figure 18. Traditional Chinese medicine application statistics in 2018 </figcaption></figure></div>



<div class="wp-block-image"><figure class="aligncenter is-resized"><img decoding="async" src="https://www.accestra.com/wp-content/uploads/2019/07/19.png" alt="" class="wp-image-2525" width="636" height="377" srcset="https://www.accestra.com/wp-content/uploads/2019/07/19.png 928w, https://www.accestra.com/wp-content/uploads/2019/07/19-300x177.png 300w, https://www.accestra.com/wp-content/uploads/2019/07/19-768x454.png 768w, https://www.accestra.com/wp-content/uploads/2019/07/19-600x355.png 600w" sizes="(max-width: 636px) 100vw, 636px" /><figcaption> Figure 19. Number of completed traditional Chinese medicine review by CDE in 2018 </figcaption></figure></div>



<div class="wp-block-image"><figure class="aligncenter is-resized"><img loading="lazy" decoding="async" src="https://www.accestra.com/wp-content/uploads/2019/07/表3-1024x263.png" alt="" class="wp-image-2526" width="762" height="196" srcset="https://www.accestra.com/wp-content/uploads/2019/07/表3-1024x263.png 1024w, https://www.accestra.com/wp-content/uploads/2019/07/表3-300x77.png 300w, https://www.accestra.com/wp-content/uploads/2019/07/表3-768x197.png 768w, https://www.accestra.com/wp-content/uploads/2019/07/表3-600x154.png 600w, https://www.accestra.com/wp-content/uploads/2019/07/表3.png 1496w" sizes="(max-width: 762px) 100vw, 762px" /><figcaption> Table 3 Detailed information of completed traditional Chinese medicine review by CDE in 2018<br> Note: &#8220;other&#8221; refers: 1) the applicant withdrawal the application, 2) Supplementary information is required from applicant after the review, 3) the application directly submitted to Drug Registration Management Bureau of NMPA instead of CDE, 4) the combination application of medical device, 5) API/excipient/package material application for linked review procedure. </figcaption></figure></div>



<p><strong>9-  Statistic of Traditional Chinese Medicine</strong> <strong> -IND</strong></p>



<div class="wp-block-image"><figure class="aligncenter"><img loading="lazy" decoding="async" width="700" height="308" src="https://www.accestra.com/wp-content/uploads/2019/07/20.jpg" alt="" class="wp-image-2527" srcset="https://www.accestra.com/wp-content/uploads/2019/07/20.jpg 700w, https://www.accestra.com/wp-content/uploads/2019/07/20-300x132.jpg 300w, https://www.accestra.com/wp-content/uploads/2019/07/20-600x264.jpg 600w" sizes="(max-width: 700px) 100vw, 700px" /><figcaption> Figure 20. Approved number of traditional Chinese medicine IND application from 2015 to 2018 </figcaption></figure></div>



<div class="wp-block-image"><figure class="aligncenter is-resized"><img loading="lazy" decoding="async" src="https://www.accestra.com/wp-content/uploads/2019/07/21.png" alt="" class="wp-image-2528" width="665" height="535" srcset="https://www.accestra.com/wp-content/uploads/2019/07/21.png 926w, https://www.accestra.com/wp-content/uploads/2019/07/21-300x242.png 300w, https://www.accestra.com/wp-content/uploads/2019/07/21-768x619.png 768w, https://www.accestra.com/wp-content/uploads/2019/07/21-600x483.png 600w" sizes="(max-width: 665px) 100vw, 665px" /><figcaption> Figure 21. Indication distribution of traditional Chinese medicine IND approved in 2018 </figcaption></figure></div>



<p> <strong>10-  Statistic of Traditional Chinese Medicine</strong> <strong>-NDA</strong></p>



<div class="wp-block-image"><figure class="aligncenter"><img loading="lazy" decoding="async" width="705" height="327" src="https://www.accestra.com/wp-content/uploads/2019/07/22.jpg" alt="" class="wp-image-2529" srcset="https://www.accestra.com/wp-content/uploads/2019/07/22.jpg 705w, https://www.accestra.com/wp-content/uploads/2019/07/22-300x139.jpg 300w, https://www.accestra.com/wp-content/uploads/2019/07/22-600x278.jpg 600w" sizes="(max-width: 705px) 100vw, 705px" /><figcaption> Figure 22. Approved number of traditional Chinese medicine NDA application from 2015 to 2018 </figcaption></figure></div>



<p> </p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
